A study highlights insufficient standardized safety and efficacy assessments for FDA-cleared AI/ML medical devices.
Key Details
- 1Cross-sectional analysis of FDA-cleared AI/ML-enabled devices was conducted.
- 2The study found lack of standardized efficacy and safety reporting in device clearance.
- 3Suggested need for dedicated regulatory pathways and post-market AI/ML safety surveillance.
- 4Study was published in JAMA Health Forum and led by Dr. Ravi B. Parikh.
Why It Matters
As imaging AI tools increasingly enter clinical use, robust regulatory oversight is critical for patient safety and clinician trust. Gaps in FDA reporting and surveillance could impact the safe integration of AI in radiology practice.
Source
EurekAlert
Related News
•EurekAlert
Holographic Neural Network Achieves Multi-Task AI via Light-Based Computing
Researchers have developed a holographic neural network using optics to perform multiple AI classification tasks simultaneously without hardware reconfiguration.
•EurekAlert
Rethinking Multimodal Cardiovascular AI: When Models Should Defer Predictions
A commentary in Medicine Discovery argues cardiovascular AI models must learn to defer predictions when key modalities are missing, as missingness and asynchrony are clinical realities.
•EurekAlert
MSKAI Unveils AI Tool for Embryo Cell Analysis and Imaging-Driven Cancer Insights
MSK researchers employ AI and advanced imaging to reveal cancer mechanisms and track embryonic development at the single-cell level.